Rite Aid Stock Price, News & Analysis (NYSE:RAD)

$2.39 0.05 (2.14 %)
(As of 01/16/2018 10:52 AM ET)
Previous Close$2.34
Today's Range$2.31 - $2.55
52-Week Range$1.38 - $8.77
Volume58.12 million shs
Average Volume40.76 million shs
Market Capitalization$2.45 billion
P/E Ratio21.73
Dividend YieldN/A
Beta1.83

About Rite Aid (NYSE:RAD)

Rite Aid logoRite Aid Corporation is a retail drugstore chain. The Company's segments include Retail Pharmacy and Pharmacy Services. The Company operates under The Rite Aid name. It operates approximately 4,560 stores in over 30 states across the country and in the District of Columbia. The Company's Retail Pharmacy segment consists of Rite Aid stores, RediClinic and Health Dialog. It sells brand and generic prescription drugs, as well as an assortment of front-end products, including health and beauty aids, personal care products, seasonal merchandise, and a private brand product line. Its front-end products include over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise and numerous other everyday and convenience products. The Company's Pharmacy Services segment consists of EnvisionRx, which provides a range of pharmacy benefit services.

Receive RAD News and Ratings via Email

Sign-up to receive the latest news and ratings for RAD and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Retail - Drugs without Grocery
Sub-IndustryDrug Retail
SectorNon-Cyclical Consumer Goods & Services
SymbolNYSE:RAD
CUSIP76775410
Phone+1-717-7612633

Debt

Debt-to-Equity Ratio3.66%
Current Ratio0.86%
Quick Ratio0.59%

Price-To-Earnings

Trailing P/E Ratio21.7272727272727
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$32.85 billion
Price / Sales0.08
Cash Flow$0.60 per share
Price / Cash3.97
Book Value$0.58 per share
Price / Book4.12

Profitability

Trailing EPS$0.11
Net Income$4.05 million
Net Margins0.53%
Return on Equity-10.19%
Return on Assets-0.61%

Miscellaneous

Employees87,000
Outstanding Shares1,067,510,000

Rite Aid (NYSE:RAD) Frequently Asked Questions

What is Rite Aid's stock symbol?

Rite Aid trades on the New York Stock Exchange (NYSE) under the ticker symbol "RAD."

How were Rite Aid's earnings last quarter?

Rite Aid Co. (NYSE:RAD) issued its quarterly earnings data on Thursday, September, 28th. The company reported ($0.01) EPS for the quarter, hitting the Thomson Reuters' consensus estimate of ($0.01). The company earned $7.68 billion during the quarter, compared to analyst estimates of $7.83 billion. Rite Aid had a negative return on equity of 10.19% and a net margin of 0.53%. Rite Aid's revenue was down 4.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.03 earnings per share. View Rite Aid's Earnings History.

When will Rite Aid make its next earnings announcement?

Rite Aid is scheduled to release their next quarterly earnings announcement on Tuesday, April, 24th 2018. View Earnings Estimates for Rite Aid.

Where is Rite Aid's stock going? Where will Rite Aid's stock price be in 2018?

9 brokers have issued twelve-month price targets for Rite Aid's shares. Their predictions range from $1.50 to $6.50. On average, they expect Rite Aid's share price to reach $2.77 in the next twelve months. View Analyst Ratings for Rite Aid.

Are investors shorting Rite Aid?

Rite Aid saw a increase in short interest during the month of December. As of December 29th, there was short interest totalling 161,693,431 shares, an increase of 0.3% from the December 15th total of 162,245,876 shares. Based on an average daily trading volume, of 19,560,045 shares, the days-to-cover ratio is currently 8.3 days. Approximately 15.4% of the company's shares are sold short.

Who are some of Rite Aid's key competitors?

Who are Rite Aid's key executives?

Rite Aid's management team includes the folowing people:

  • John T. Standley, Chairman of the Board, Chief Executive Officer (Age 54)
  • Kermit Crawford, President, Chief Operating Officer (Age 58)
  • Darren W. Karst, Chief Financial Officer, Senior Executive Vice President, Chief Administrative Officer (Age 57)
  • Bryan Everett, Chief Operating Officer (Age 44)
  • David Abelman, Executive Vice President - Marketing (Age 57)
  • Derek Griffith, Executive Vice President - Store Operations
  • Jocelyn Z. Konrad, Executive Vice President - Pharmacy (Age 47)
  • Matt Schroeder, Senior Vice President, Chief Accounting Officer, Treasurer
  • Michael N. Regan, Lead Independent Director (Age 69)
  • Joseph B. Anderson Jr., Independent Director (Age 72)

How do I buy Rite Aid stock?

Shares of Rite Aid can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Rite Aid's stock price today?

One share of Rite Aid stock can currently be purchased for approximately $2.30.

How big of a company is Rite Aid?

Rite Aid has a market capitalization of $2.54 billion and generates $32.85 billion in revenue each year. The company earns $4.05 million in net income (profit) each year or $0.11 on an earnings per share basis. Rite Aid employs 87,000 workers across the globe.

How can I contact Rite Aid?

Rite Aid's mailing address is 30 Hunter Ln, CAMP HILL, PA 17011-2400, United States. The company can be reached via phone at +1-717-7612633 or via email at [email protected]


MarketBeat Community Rating for Rite Aid (RAD)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  346 (Vote Outperform)
Underperform Votes:  330 (Vote Underperform)
Total Votes:  676
MarketBeat's community ratings are surveys of what our community members think about Rite Aid and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Rite Aid (NYSE:RAD) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.002.002.002.00
Ratings Breakdown: 2 Sell Rating(s)
5 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
5 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
5 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
3 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $2.77$2.88$3.41$4.19
Price Target Upside: 33.28% upside50.17% upside74.04% upside59.38% upside

Rite Aid (NYSE:RAD) Consensus Price Target History

Price Target History for Rite Aid (NYSE:RAD)

Rite Aid (NYSE:RAD) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/4/2018Evercore ISIInitiated CoverageUnderperform -> Underperform$1.50MediumView Rating Details
12/4/2017Deutsche BankInitiated CoverageHold$2.25MediumView Rating Details
10/25/2017Royal Bank of CanadaSet Price TargetHold$2.00N/AView Rating Details
10/7/2017MizuhoSet Price TargetHold$2.00N/AView Rating Details
10/2/2017GuggenheimReiterated RatingNeutral$2.00LowView Rating Details
9/29/2017Loop CapitalReiterated RatingHold -> Hold$2.50 -> $2.00HighView Rating Details
7/3/2017CowenReiterated RatingOutperform$4.70HighView Rating Details
6/30/2017Bank of AmericaReiterated RatingUnderperform$2.00HighView Rating Details
3/20/2017Credit Suisse GroupReiterated RatingOutperform$6.50LowView Rating Details
6/17/2016JPMorgan Chase & Co.Reiterated RatingHoldN/AView Rating Details
(Data available from 1/16/2016 forward)

Earnings

Rite Aid (NYSE:RAD) Earnings History and Estimates Chart

Earnings by Quarter for Rite Aid (NYSE:RAD)

Rite Aid (NYSE RAD) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/24/2018        
9/28/2017Q2 2018($0.01)($0.01)$7.83 billion$7.68 billionViewN/AView Earnings Details
6/29/2017Q1 2018($0.01)($0.05)$8.29 billion$7.78 billionViewN/AView Earnings Details
12/22/2016Q317$0.04$0.02$8.23 billion$8.09 billionViewN/AView Earnings Details
9/22/2016Q2$0.03$0.03$8.09 billion$8.03 billionViewN/AView Earnings Details
6/16/2016Q117$0.05$0.01$8.23 billion$8.18 billionViewN/AView Earnings Details
4/7/2016Q416$0.06$0.07$8.47 billion$8.27 billionViewN/AView Earnings Details
12/17/2015Q316$0.06$0.06$8.20 billion$8.15 billionViewN/AView Earnings Details
9/17/2015Q216$0.03$0.02$7.60 billion$7.66 billionViewListenView Earnings Details
6/18/2015Q116$0.03$0.04$6.65 billion$6.60 billionViewListenView Earnings Details
4/8/2015Q415$0.07$0.12$6.79 billion$6.85 billionViewN/AView Earnings Details
12/18/2014Q315$0.05$0.10$6.55 billion$6.70 billionViewListenView Earnings Details
9/18/2014Q215$0.06$0.13$6.49 billion$6.52 billionViewListenView Earnings Details
6/19/2014Q115$0.05$0.04$6.43 billion$6.47 billionViewListenView Earnings Details
4/10/2014Q414$0.04$0.10$6.54 billion$6.60 billionViewListenView Earnings Details
12/19/2013Q314$0.04$0.04$6.30 billion$6.36 billionViewListenView Earnings Details
9/19/2013Q2 2014($0.04)$0.03$6.27 billion$6.30 billionViewListenView Earnings Details
6/20/2013Q1 2014$0.09$0.09$6.27 billion$6.30 billionViewListenView Earnings Details
4/11/2013Q4 2013($0.02)$0.13$6.47 billion$6.50 billionViewListenView Earnings Details
12/20/2012Q3 2013($0.03)$0.07$6.28 billion$6.24 billionViewListenView Earnings Details
9/20/2012Q213($0.07)($0.05)$6.20 billion$6.20 billionViewN/AView Earnings Details
6/21/2012($0.03)($0.03)ViewN/AView Earnings Details
4/12/2012($0.17)($0.18)ViewN/AView Earnings Details
12/15/2011($0.13)($0.06)ViewN/AView Earnings Details
9/22/2011($0.17)($0.11)ViewN/AView Earnings Details
6/23/2011($0.12)($0.07)ViewN/AView Earnings Details
4/7/2011($0.24)($0.24)ViewN/AView Earnings Details
12/16/2010($0.13)($0.09)$6.20 billion$6.20 billionViewN/AView Earnings Details
9/23/2010Q2 2011($0.16)($0.18)ViewN/AView Earnings Details
6/23/2010Q1 2011($0.14)($0.09)ViewN/AView Earnings Details
3/31/2010Q4 2010($0.19)($0.24)ViewN/AView Earnings Details
12/17/2009Q3 2010($0.18)($0.10)ViewN/AView Earnings Details
9/24/2009Q2 2010($0.15)($0.14)ViewN/AView Earnings Details
6/24/2009Q1 2010($0.13)($0.11)ViewN/AView Earnings Details
4/2/2009Q4 2009($0.11)($0.14)ViewN/AView Earnings Details
12/18/2008Q3 2009($0.17)($0.17)ViewN/AView Earnings Details
9/25/2008Q2 2009($0.14)($0.27)ViewN/AView Earnings Details
6/26/2008Q1 2009($0.09)($0.20)ViewN/AView Earnings Details
4/10/2008Q4 2008($0.07)($0.07)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Rite Aid (NYSE:RAD) Earnings Estimates

2018 EPS Consensus Estimate: $0.22
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181$0.03$0.03$0.03
Q2 20181$0.04$0.04$0.04
Q3 20181$0.08$0.08$0.08
Q4 20181$0.07$0.07$0.07
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Dividend History for Rite Aid (NYSE:RAD)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Rite Aid (NYSE RAD) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 2.29%
Institutional Ownership Percentage: 50.72%
Insider Trades by Quarter for Rite Aid (NYSE:RAD)
Institutional Ownership by Quarter for Rite Aid (NYSE:RAD)

Rite Aid (NYSE RAD) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/3/2017Myrtle S PotterDirectorSell28,189$2.09$58,915.01View SEC Filing  
6/15/2016Douglas E DonleySVPSell34,106$7.77$265,003.6282,885View SEC Filing  
7/9/2015Tony MontiniEVPSell353,194$8.38$2,959,765.72View SEC Filing  
4/15/2015Joseph B Anderson JrDirectorSell150,000$8.25$1,237,500.00View SEC Filing  
4/13/2015Robert K ThompsonEVPSell95,850$8.33$798,430.50View SEC Filing  
4/10/2015Douglas E DonleyCAOSell59,404$8.21$487,706.84View SEC Filing  
4/10/2015Marcy SymsDirectorSell150,000$8.26$1,239,000.00View SEC Filing  
12/29/2014Tony MontiniEVPSell49,525$7.47$369,951.75View SEC Filing  
12/23/2014Tony MontiniEVPSell259,750$6.92$1,797,470.00View SEC Filing  
12/22/2014John T StandleyCEOSell1,700,000$6.82$11,594,000.00View SEC Filing  
12/22/2014Kenneth MartindaleCOOSell1,043,400$6.80$7,095,120.00View SEC Filing  
12/22/2014Robert Ivan ThompsonEVPSell149,231$6.80$1,014,770.80View SEC Filing  
7/3/2014Robert Ivan ThompsonEVPSell249,583$7.48$1,866,880.84View SEC Filing  
6/24/2014Joseph B Anderson JrDirectorSell26,667$7.05$188,002.35View SEC Filing  
6/23/2014Robert Ivan ThompsonEVPSell510,000$7.06$3,600,600.00View SEC Filing  
4/22/2014Marc StrasslerEVPSell224,800$7.12$1,600,576.00699,369View SEC Filing  
4/21/2014Frank VitranoEVPSell1,913,925$7.08$13,550,589.001,183,384View SEC Filing  
4/16/2014Robert Ivan ThompsonEVPSell25,566$7.03$179,728.98749,882View SEC Filing  
2/19/2014John StandleyCEOSell1,200,000$6.23$7,476,000.002,974,958View SEC Filing  
2/19/2014Kenneth MartindaleCOOSell666,667$6.23$4,153,335.411,193,252View SEC Filing  
1/21/2014Douglas DonleySVPSell24,173$5.79$139,961.6781,628View SEC Filing  
1/3/2014John StandleyCEOSell600,000$5.48$3,288,000.002,974,958View SEC Filing  
1/3/2014Kenneth MartindaleCOOSell333,333$5.48$1,826,664.841,193,252View SEC Filing  
10/18/2013Robert K ThompsonEVPSell250,000$5.27$1,317,500.00View SEC Filing  
10/17/2013Douglas E DonleySVPSell88,700$5.27$467,449.00View SEC Filing  
10/17/2013Marc A StrasslerEVPSell100,000$5.31$531,000.00View SEC Filing  
10/14/2013Frank VitranoCFOSell1,982,900$5.00$9,914,500.001,183,384View SEC Filing  
10/4/2013Tony MontiniEVPSell414,500$5.21$2,159,545.00643,713View SEC Filing  
9/25/2013Robert Ivan ThompsonEVPSell400,000$4.81$1,924,000.00749,882View SEC Filing  
7/18/2013Robert K ThompsonEVPSell401,655$3.01$1,208,981.55View SEC Filing  
7/16/2013David JessickInsiderSell100,000$2.93$293,000.00View SEC Filing  
7/16/2013Marc A StrasslerEVPSell375,000$2.96$1,110,000.00View SEC Filing  
7/12/2013Douglas E DonleySVPSell6,899$2.80$19,317.20View SEC Filing  
7/11/2013Douglas E DonleySVPSell75,378$2.78$209,550.84View SEC Filing  
7/11/2013Robert Ivan ThompsonEVPSell375,000$2.75$1,031,250.00View SEC Filing  
6/26/2013Jean Coutu Group (Pjc) Inc.Major ShareholderSell40,500,000$2.75$111,375,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Rite Aid (NYSE RAD) News Headlines

Source:
DateHeadline
[$$] Rite Sizing[$$] Rite Sizing
finance.yahoo.com - January 16 at 6:05 AM
Rite Aid (RAD) Downgraded by Vetr to BuyRite Aid (RAD) Downgraded by Vetr to Buy
www.americanbankingnews.com - January 14 at 8:50 PM
Rite Aid (RAD) Soars Too High Too Fast: Is This Justified? - Nasdaq ... - NasdaqRite Aid (RAD) Soars Too High Too Fast: Is This Justified? - Nasdaq ... - Nasdaq
www.nasdaq.com - January 12 at 5:52 AM
Here’s Where You Can Still Get a 2018 Flu Shot and How Much It Will Cost YouHere’s Where You Can Still Get a 2018 Flu Shot and How Much It Will Cost You
finance.yahoo.com - January 12 at 5:52 AM
Rite Aid Urges People to Get Vaccinated Against the Flu as Flu Activity IncreasesRite Aid Urges People to Get Vaccinated Against the Flu as Flu Activity Increases
finance.yahoo.com - January 11 at 3:18 PM
What Remains For Rite Aid Corporation? The Risks of Going It AloneWhat Remains For Rite Aid Corporation? The Risks of Going It Alone
investorplace.com - January 11 at 1:17 PM
Why I’m Still Bullish on a Rite Aid Corporation Stock TurnaroundWhy I’m Still Bullish on a Rite Aid Corporation Stock Turnaround
investorplace.com - January 11 at 7:40 AM
Rite Aid Is Outperforming the S&P 500 So Far in 2018: Here Are 5 Reasons WhyRite Aid Is Outperforming the S&P 500 So Far in 2018: Here Are 5 Reasons Why
www.fool.com - January 11 at 6:28 AM
Walgreens’s US Pharmacy Sales Strong, Retail Sales Still SoftWalgreens’s US Pharmacy Sales Strong, Retail Sales Still Soft
finance.yahoo.com - January 11 at 5:58 AM
The Rite Aid Corporation Stock Rebound Is Brewing up Quite NicelyThe Rite Aid Corporation Stock Rebound Is Brewing up Quite Nicely
investorplace.com - January 11 at 5:35 AM
Stock Watch: No Respite for Rite Aid’s ShareholdersStock Watch: No Respite for Rite Aid’s Shareholders
finance.yahoo.com - January 10 at 3:19 PM
Walgreens Beats 1Q18 Sales and Earnings ExpectationsWalgreens Beats 1Q18 Sales and Earnings Expectations
finance.yahoo.com - January 10 at 3:19 PM
Rite Aid (RAD) Downgraded by Zacks Investment Research to SellRite Aid (RAD) Downgraded by Zacks Investment Research to Sell
www.americanbankingnews.com - January 9 at 10:36 AM
Rite Aid (RAD) a Sell on Flopping Quant Score | InvestorPlace - Investorplace.comRite Aid (RAD) a Sell on Flopping Quant Score | InvestorPlace - Investorplace.com
investorplace.com - January 9 at 6:34 AM
Rite Aid Co. (RAD) Receives Consensus Rating of "Hold" from AnalystsRite Aid Co. (RAD) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - January 8 at 6:02 PM
Rite Aids Poison Pill - Seeking AlphaRite Aid's Poison Pill - Seeking Alpha
seekingalpha.com - January 6 at 3:18 PM
Lousy Industry Group Rank Make Rite Aid (RAD) a Sell - Investorplace.comLousy Industry Group Rank Make Rite Aid (RAD) a Sell - Investorplace.com
investorplace.com - January 6 at 3:18 PM
Rite Aid Is Cheap For A Reason - Seeking AlphaRite Aid Is Cheap For A Reason - Seeking Alpha
seekingalpha.com - January 6 at 3:18 PM
LB-UBS Commercial Mortgage Trust 2004-C4 -- Moodys Affirms Two Classes of LBUBS 2004-C4LB-UBS Commercial Mortgage Trust 2004-C4 -- Moody's Affirms Two Classes of LBUBS 2004-C4
finance.yahoo.com - January 5 at 3:19 PM
Lousy Industry Group Rank Make Rite Aid (RAD) a SellLousy Industry Group Rank Make Rite Aid (RAD) a Sell
investorplace.com - January 5 at 10:34 AM
Rite Aid (RAD) Q3 Earnings Beat, Stores Transfer on Track - Yahoo FinanceRite Aid (RAD) Q3 Earnings Beat, Stores Transfer on Track - Yahoo Finance
finance.yahoo.com - January 5 at 6:02 AM
Rite Aid (RAD) Research Coverage Started at Evercore ISIRite Aid (RAD) Research Coverage Started at Evercore ISI
www.americanbankingnews.com - January 4 at 5:04 PM
Battle of the drug stores heats up as Walgreens buys Rite AidBattle of the drug stores heats up as Walgreens buys Rite Aid
www.msn.com - January 4 at 3:18 PM
Rite Aid misses revenue estimate, shares fall 12 percentRite Aid misses revenue estimate, shares fall 12 percent
www.reuters.com - January 4 at 3:18 PM
Rite Aid (RAD) Q3 Earnings Beat, Stores Transfer on TrackRite Aid (RAD) Q3 Earnings Beat, Stores Transfer on Track
finance.yahoo.com - January 4 at 3:18 PM
Here’s Why Rite Aid Corporation Stock Keeps Getting WorseHere’s Why Rite Aid Corporation Stock Keeps Getting Worse
investorplace.com - January 4 at 10:26 AM
3 Stocks to Watch on Thursday: Intel Corporation (INTC), Rite Aid Corporation (RAD) and Zumiez Inc. (ZUMZ)3 Stocks to Watch on Thursday: Intel Corporation (INTC), Rite Aid Corporation (RAD) and Zumiez Inc. (ZUMZ)
investorplace.com - January 4 at 8:13 AM
Why JC Penney, Rite Aid, and Alibaba Group Holding Jumped Today - Motley FoolWhy JC Penney, Rite Aid, and Alibaba Group Holding Jumped Today - Motley Fool
www.fool.com - January 4 at 5:56 AM
After-Hours Earnings Report for January 3, 2018 : RAD, RECN, LNDC - NasdaqAfter-Hours Earnings Report for January 3, 2018 : RAD, RECN, LNDC - Nasdaq
www.nasdaq.com - January 4 at 5:56 AM
Analytics for Quant Score Keep Rite Aid (RAD) a Sell - Investorplace.comAnalytics for Quant Score Keep Rite Aid (RAD) a Sell - Investorplace.com
investorplace.com - January 4 at 5:56 AM
Rite Aids (RAD) CEO John Standley on Q3 2018 Results - Earnings Call Transcript - Seeking AlphaRite Aid's (RAD) CEO John Standley on Q3 2018 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - January 4 at 5:56 AM
Rite Aid misses revenue estimate, shares fallRite Aid misses revenue estimate, shares fall
finance.yahoo.com - January 4 at 5:55 AM
Edited Transcript of RAD earnings conference call or presentation 3-Jan-18 10:00pm GMTEdited Transcript of RAD earnings conference call or presentation 3-Jan-18 10:00pm GMT
finance.yahoo.com - January 4 at 5:55 AM
Rite Aid Corporation (RAD) Q3 2018 Earnings Conference Call TranscriptRite Aid Corporation (RAD) Q3 2018 Earnings Conference Call Transcript
finance.yahoo.com - January 4 at 5:55 AM
Smaller Rite Aid Plans To Grow PBMs Medicare Prescription BusinessSmaller Rite Aid Plans To Grow PBM's Medicare Prescription Business
finance.yahoo.com - January 4 at 5:55 AM
What To Expect From Rite Aid, Walgreens Boots Alliance EarningsWhat To Expect From Rite Aid, Walgreens Boots Alliance Earnings
finance.yahoo.com - January 3 at 11:17 AM
Rite Aid Co. (RAD) Sees Large Decrease in Short InterestRite Aid Co. (RAD) Sees Large Decrease in Short Interest
www.americanbankingnews.com - January 3 at 1:50 AM
Rite Aid Stock Has a Lot to Prove on Wednesday - Motley FoolRite Aid Stock Has a Lot to Prove on Wednesday - Motley Fool
www.fool.com - January 2 at 6:07 AM
Rite Aid Stock Has a Lot to Prove on WednesdayRite Aid Stock Has a Lot to Prove on Wednesday
www.fool.com - January 1 at 12:24 PM
Monsanto, Rite Aid and More Earnings Kicking Off the New Year - 24/7 Wall St.Monsanto, Rite Aid and More Earnings Kicking Off the New Year - 24/7 Wall St.
247wallst.com - December 31 at 3:19 PM
3 Retail Stocks to Buy for 2018 -- The Motley Fool - Motley Fool3 Retail Stocks to Buy for 2018 -- The Motley Fool - Motley Fool
www.fool.com - December 29 at 3:17 PM
Will Rite Aids (RAD) Strategies Aid Earnings Growth in Q3? - NasdaqWill Rite Aid's (RAD) Strategies Aid Earnings Growth in Q3? - Nasdaq
www.nasdaq.com - December 29 at 3:17 PM
Will Rite Aid's (RAD) Strategies Aid Earnings Growth in Q3?Will Rite Aid's (RAD) Strategies Aid Earnings Growth in Q3?
finance.yahoo.com - December 29 at 9:23 AM
Surprise! Rite Aid Corporation Looks Ready For Decent GainSurprise! Rite Aid Corporation Looks Ready For Decent Gain
investorplace.com - December 28 at 12:36 PM
3 Retail Stocks to Buy for 20183 Retail Stocks to Buy for 2018
www.fool.com - December 28 at 10:57 AM
Rite Aid (RAD) a Sell on Falling Quant ScoreRite Aid (RAD) a Sell on Falling Quant Score
investorplace.com - December 28 at 10:18 AM
Why Rite Aid Corporation Stock Has 25% UpsideWhy Rite Aid Corporation Stock Has 25% Upside
investorplace.com - December 27 at 11:50 AM
Rite Aid (RAD) Set to Announce Earnings on WednesdayRite Aid (RAD) Set to Announce Earnings on Wednesday
www.americanbankingnews.com - December 27 at 1:44 AM
$7.74 Billion in Sales Expected for Rite Aid Co. (RAD) This Quarter$7.74 Billion in Sales Expected for Rite Aid Co. (RAD) This Quarter
www.americanbankingnews.com - December 26 at 10:30 PM
 Analysts Expect Rite Aid Co. (RAD) to Post -$0.02 Earnings Per Share Analysts Expect Rite Aid Co. (RAD) to Post -$0.02 Earnings Per Share
www.americanbankingnews.com - December 24 at 11:28 AM

SEC Filings

Rite Aid (NYSE:RAD) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Rite Aid (NYSE:RAD) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Rite Aid (NYSE RAD) Stock Chart for Tuesday, January, 16, 2018

Loading chart…

This page was last updated on 1/16/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.